Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 415 results for "cadila health"

Zydus completes single rising dose Phase I studies for its ora...

Cadila Healthcare Ltd has informed BSE regarding a Press Release dated February 16, 2015 titled " for treating Anemia and initiates multiple dosing studies".Source : BSE Read all announcements in Cadila Health To read the full report Moneycontrol.com, 2 weeks ago
Cadila Healthcare recalls cough treatment drug in US Indian-Commodity, 1 month ago
Cadila recalls 19,536 bottles of cough treatment drug in US Business Standard India, 1 month ago
[x]  

Cadila Health consolidated Dec '14 sales at Rs 2,189.46 crore

Cadila Healthcare has reported a consolidated total income from operations of Rs 2,189.46 crore and a net profit of Rs 281.91 crore for the quarter ended
 Moneycontrol.com3 weeks ago Buy Cadila Health, target of Rs 1,763: Nomura  Financial Express1 month ago Cadila Healthcare unveils cheaper copy of top drug  Asian Age2 months ago
Business Standard India

Zydus Wellness launches herbal variant of Sugar Free

Related to : Zydus Wellness Ltd,Cadila Healthcare Ltd Zydus Wellness Ltd BSE 11 Feb 15 | 12:00 AM 818.10 -20.25 (-2.42%) NSE 11 Feb 15 | 12:00 AM 820.95 -20.3 (-2.41%) Zydus Wellness, the consumer products arm of Ahmedabad-based ...
 Smart Investor3 weeks ago Wockhardt, Cadila and Hospira voluntarily recall drugs in US  Economic Times2 months ago Trio recall drugs in US  Calcutta Telegraph2 months ago Three drugs firms recall select lot of drugs in the U.S.  The Hindu2 months ago
[x]  

India's Cadila, Dr Reddy's Rise on Sales Data — Market Talk

1006 GMT [Dow Jones] Indian generic drug makers Cadila Healthcare (532321.BY) and Dr. Reddy's Laboratories (500124.BY) are up 0.4% and 1.5% respectively after IMS Health flags strong January sales for both. The market research firm says three-month ...
 iMarketReports1 day ago India's Cadila launches first cheaper copy of world's top-selling drug  Reuters2 months ago Cadila launches first cheaper copy of world's top-selling drug  The Financial Chronicle2 months ago

Cadila Healthcare advances despite recalling cough treatment drug in US

Cadila Healthcare is currently trading at Rs. 1705.65, up by 59.40 points or 3.61% from its previous closing of Rs. 1646.25 on the BSE. The scrip opened at Rs. 1662.35 and has touched a high and low of Rs. 1717.95 and Rs. 1662.35 respectively. So ...
 Arihant Capital1 month ago

Cadila Healthcare Ltd clarifies on voluntary recall of drugs in US

Posted On: 2015-01-01 00:28:49 The Exchange had sought clarification from Cadila Healthcare Ltd with respect to news appearing in Economic Times on December 31, 2014 titled "Wockhardt, Cadila & Hospira voluntarily recall drugs in US."Cadila ...
 Equity Bulls2 months ago Cadila recalls Benzonatate capsules from US markets  The Financial Chronicle2 months ago Wockhardt Ltd clarifies on recall of drugs in US  Equity Bulls2 months ago

Cadila Healthcare gains on plan to develop vaccines for Congo Virus and Ebola Virus

Cadila Healthcare is currently trading at Rs. 1606.00, up by 7.65 points or 0.48% from its previous closing of Rs. 1598.35 on the BSE. The scrip opened at Rs. 1610.00 and has touched a high and low of Rs. 1619.00 and Rs. 1600.00 respectively. So ...
 Arihant Capital2 months ago Cadila Healthcare edges up on plans of developing vaccines for Congo Virus and Ebola Virus  Arihant Capital2 months ago
Financial Express

The Gujarat Model: Is it the way forward?

Gujarat has done very well in some sectors but with its health indicators still lagging behind, will it be the blueprint for the rest of India? By Raelene Kambli Sickle Cell Anemia Control Programme Gujarat's model of development has been ...
 Financial Express1 month ago
AhmedabadMirror.com

No economic development without good health: WHO

To boost the healthcare sector in Gujarat the state government signed more than 270 MoUs with hospitals and pharmaceutical companies at the seventh Vibrant Gujarat Global Investor Summit on Monday. The major companies included Gujarat Cancer ...
 AhmedabadMirror.com1 month ago Pharma: In the best of health  Hindu Business Line2 months ago

Market edges higher in late trade

Sensex was provisionally up 32.30 points or 0.12% to 27,240.91. The market breadth indicating the overall health of the market was negative. Shares of most pharmaceutical companies rose. IT stocks were mixed. Meanwhile, foreign portfolio investors ...
 Business Standard India2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less